
Pam Belluck
Health and Science Reporter at The New York Times
New York Times writer covering health & science. Author of "Island Practice," a book about a quirky island doctor. Jazz flutist. Lapsed Ultimate Frisbee player.
Articles
-
2 weeks ago |
nytimes.com | Pam Belluck |Hannah Yoon
A nurse practitioner spoke on the phone with patients in states with abortion bans, assessed their medical eligibility and sent pills. She took some unconventional steps to protect their privacy. Debra Lynch, a nurse practitioner who operates the service Her Safe Harbor, during a call with a patient interested in abortion medication. A nurse practitioner spoke on the phone with patients in states with abortion bans, assessed their medical eligibility and sent pills.
-
3 weeks ago |
nytimes.com | Pam Belluck
The states consider it a move to force the F.D.A. to review and acknowledge extensive research showing the pill's safety. In a strategy aimed at countering efforts to further restrict the abortion pill mifepristone, attorneys general of four states that support abortion rights on Thursday asked the Food and Drug Administration to do the opposite and lift the most stringent remaining restrictions on the pill.
-
1 month ago |
nytimes.com | Rachel Abrams |Pam Belluck |Alex Stern |Will Reid |Diana Nguyen |Mary Wilson | +6 more
Fact-checking by Susan Lee. The Daily is made by Rachel Quester, Lynsea Garrison, Clare Toeniskoetter, Paige Cowett, Michael Simon Johnson, Brad Fisher, Chris Wood, Jessica Cheung, Stella Tan, Alexandra Leigh Young, Lisa Chow, Eric Krupke, Marc Georges, M.J. Davis Lin, Dan Powell, Sydney Harper, Michael Benoist, Liz O.
-
1 month ago |
nytimes.com | Pam Belluck
Se trata de un paso hacia el objetivo de algún día poder diagnosticar la enfermedad con el pinchazo de un dedo. Una prueba de sangre que puede ayudar a diagnosticar la enfermedad de Alzheimer ha recibido la autorización de la Administración de Alimentos y Medicamentos (FDA por su sigla en inglés). Se trata de un paso hacia el objetivo de científicos y médicos de poder diagnosticar algún día una enfermedad confusa con el pinchazo de un dedo. Pero aún queda mucho camino por recorrer.
-
1 month ago |
myheraldreview.com | Pam Belluck
A blood test that can help diagnose Alzheimer’s disease has received clearance from the Food and Drug Administration. This is a step toward a goal of scientists and doctors to one day be able to diagnose a confounding illness with the prick of a finger. But there is still a long way to go. Here is what to know:kAmkDEC@?8m(92E :D E96 E6DE[ 2?5 9@H D9@F=5 :E 36 FD65nk^DEC@?8mk^AmkAm%96 E6DE[ >2?F724EFC65 3J uF;:C63:@ s:28?@DE:4D[ :D :?E6?565 E@ 36 FD65 @?=J 3J DA64:2=:DED :?
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →Coverage map
X (formerly Twitter)
- Followers
- 11K
- Tweets
- 7K
- DMs Open
- Yes

NEW: Four states are petitioning the FDA to lift the special set of restrictions it applies to the abortion pill mifepristone. It's an effort to counter anti-abortion pressure to further restrict access to the pill. https://t.co/f4JZBV3oQi

Today's episode of The Daily: "A New Front Line for Abortion Rights" https://t.co/bB3KLesnHz

NEW: Trump administration asks court to dismiss abortion pill case https://t.co/49VdnIwqmI